165 related articles for article (PubMed ID: 26361955)
1. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
[TBL] [Abstract][Full Text] [Related]
2. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
[TBL] [Abstract][Full Text] [Related]
3. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
[TBL] [Abstract][Full Text] [Related]
4. Integrative meta-analysis of multiple gene expression profiles in acquired gemcitabine-resistant cancer cell lines to identify novel therapeutic biomarkers.
Lee YS; Kim JK; Ryu SW; Bae SJ; Kwon K; Noh YH; Kim SY
Asian Pac J Cancer Prev; 2015; 16(7):2793-800. PubMed ID: 25854364
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract][Full Text] [Related]
6. Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer.
Bao S; Chen Y; Yang F; Sun C; Yang M; Li W; Huang X; Li J; Wu H; Yin Y
Front Pharmacol; 2020; 11():577150. PubMed ID: 33013420
[TBL] [Abstract][Full Text] [Related]
7. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
[TBL] [Abstract][Full Text] [Related]
8. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
9. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
Zhou W; Ma CX; Xing YZ; Yan ZY
Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
[TBL] [Abstract][Full Text] [Related]
11. Identification of breast cancer mechanism based on weighted gene coexpression network analysis.
Guo X; Xiao H; Guo S; Dong L; Chen J
Cancer Gene Ther; 2017 Aug; 24(8):333-341. PubMed ID: 28799567
[TBL] [Abstract][Full Text] [Related]
12. Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.
Zang H; Li N; Pan Y; Hao J
Gynecol Endocrinol; 2017 Mar; 33(3):193-198. PubMed ID: 27809618
[TBL] [Abstract][Full Text] [Related]
13. Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis.
Kim D; Lee YS; Kim JK; Kim SY
Crit Rev Eukaryot Gene Expr; 2019; 29(6):581-597. PubMed ID: 32422012
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
15. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods.
Azad AKM; Alyami SA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33857297
[TBL] [Abstract][Full Text] [Related]
16. Construction of an immunorelated protein-protein interaction network for clarifying the mechanism of burn.
Gao Y; Nai W; Yang L; Lu Z; Shi P; Jin H; Wen H; Wang G
Burns; 2016 Mar; 42(2):405-13. PubMed ID: 26739088
[TBL] [Abstract][Full Text] [Related]
17. Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-estradiol (E2).
Huan J; Wang L; Xing L; Qin X; Feng L; Pan X; Zhu L
Gene; 2014 Jan; 533(1):346-55. PubMed ID: 23978611
[TBL] [Abstract][Full Text] [Related]
18. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis.
Wu D; Han B; Guo L; Fan Z
J Obstet Gynaecol; 2016 Jul; 36(5):615-21. PubMed ID: 26804550
[TBL] [Abstract][Full Text] [Related]
20. Unique gene expression profile in osteoarthritis synovium compared with cartilage: analysis of publicly accessible microarray datasets.
Park R; Ji JD
Rheumatol Int; 2016 Jun; 36(6):819-27. PubMed ID: 26942917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]